Ligand Pharmaceuticals, Inc. (LGND) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Ligand Pharmaceuticals, Inc. · Health Care · ref. ETF XLV · 65 calls · price $303.53
What the company does: Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.
📈 Ligand Pharmaceuticals, Inc. (LGND) stock price
$303.53+67.8% over range
Oct 14, 25low $180.77 · high $322.61Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
100% recommend buying · 8 analysts
📊 JPI status : Ligand Pharmaceuticals, Inc. has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 LGND price target & analyst consensus — price $304
The price target · all analysts combined (8 targets)
Highest target · 1 firm of 8$397+30.8%
Median target · of 8 targets$345+13.7%
Lowest target · 1 firm of 8$326+7.4%
Current price$303.53
Where these 8 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
8100%
$326 ↔ $397
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Leerink Partners — 64% of its targets hit on this sector (11 calls tested). It aims for $330 (+8.7 %), call made on August 15, 2026, maturing on August 15, 2027 (60 d ago).
The 2 reliable analysts
$344+13 %
The 6 other firms
$345+14 %
How to read it: the 2 reliable firms are not filtered by optimism — 2 aim above the price, 0 below, hence their $344 median. “The 6 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 8 ratings (last 6 months)
Strong Buy00%
Buy8100%
Hold00%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 LGND price target all
All 65 calls, one by one, with our verdict on each firm.
→ See all 65 targets, analyst by analyst💡 The best analysts on LGND most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in LGND? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Ligand Pharmaceuticals, Inc.? The JPI assistant answers using our backtest data.
🔎 Detailed analyses
✅ Historical analyst reliability on LGND
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Oppenheimer ↗ | 100% | +90.5% | 6 |
| RBC Capital ↗ | 100% | +61.3% | 6 |
| Benchmark ↗ | 100% | +54.8% | 11 |
| Craig-Hallum ↗ | 100% | +43.3% | 3 |
| HC Wainwright & Co. ↗ | 80% | +30.8% | 20 |
| Roth Capital | 71% | +3.2% | 7 |
| Deutsche Bank ↗ | 67% | +27.1% | 3 |
| Cantor Fitzgerald ↗ | 50% | +84.1% | 2 |
| Stephens & Co. ↗ | 50% | +14.7% | 2 |
| Barclays ↗ | 46% | +8.6% | 13 |
📊 What $1,000 invested in Ligand Pharmaceuticals, Inc. would be worth › open the full page
In short — $1,000 invested in Ligand Pharmaceuticals, Inc. 10 years ago would be worth $4,450 today, i.e. +16%/yr on average. Best year: 2025 (+76%), worst: 2022 (-31%). Price performance, excluding dividends.
If I'd invested $1,000 in Ligand Pharmaceuticals, Inc.
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $2,809 | +181% |
| 3 years ago | $4,506 | +351% |
| 5 years ago | $4,851 | +385% |
Return by year (Ligand Pharmaceuticals, Inc.)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +59% | $1,592 (+59%) |
| 2025 | +76% | $2,809 (+181%) |
| 2024 | +50% | $4,214 (+321%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Ligand Pharmaceuticals, Inc.
Loading news…
📋 All analyst calls on LGND
Filtered on — · ✕ show all
▲ Overweight · 🎯$345
Price at call : $301.52 — upside +14%
Today : $303.53 — upside +14%
🎯 on LGND : 100% (3 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Sep 25, 27
matures : Sep 25, 27
HC Wainwright & Co. ↗
Sep 24, 26
▲ Buy · 🎯$358
Price at call : $301.52 — upside +19%
Today : $303.53 — upside +18%
🎯 on LGND : 100% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Sep 24, 27
matures : Sep 24, 27
▲ Buy · 🎯$397
Price at call : $299.04 — upside +33%
Today : $303.53 — upside +31%
🎯 on LGND : no call matured yet · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : Sep 23, 27
matures : Sep 23, 27
Leerink Partners ↗
Aug 14, 26
▲ Outperform · 🎯$330
Price at call : $291.77 — upside +13%
Today : $303.53 — upside +9%
🎯 on LGND : no call matured yet · 📊 on Health : 54.5% · +7.0% (11 calls)
in progress (365j)
matures : Aug 14, 27
matures : Aug 14, 27
RBC Capital ↗
Aug 7, 26
▲ Outperform · 🎯$345
Price at call : $295.7 — upside +17%
Today : $303.53 — upside +14%
🎯 on LGND : 100% (4 calls matureds) · 📊 on Health : 31.1% · -10.5% (167 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
HC Wainwright & Co. ↗
Aug 6, 26
▲ Buy · 🎯$358
Price at call : $293.15 — upside +22%
Today : $303.53 — upside +18%
🎯 on LGND : 100% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
Oppenheimer ↗
Aug 3, 26
▲ Outperform · 🎯$326
Price at call : $300.79 — upside +8%
Today : $303.53 — upside +7%
🎯 on LGND : 100% (6 calls matureds) · 📊 on Health : 47.4% · +5.9% (95 calls)
in progress (365j)
matures : Aug 3, 27
matures : Aug 3, 27
RBC Capital ↗
Jul 15, 26
▲ Outperform · 🎯$340
Price at call : $296.45 — upside +15%
Today : $303.53 — upside +12%
🎯 on LGND : 100% (4 calls matureds) · 📊 on Health : 31.1% · -10.5% (167 calls)
in progress (365j)
matures : Jul 15, 27
matures : Jul 15, 27
See the other 57 calls, newest to oldest
B of A Securities ↗
Jul 9, 26
▲ Buy · 🎯$388
Price at call : $322.61 — upside +20%
Today : $303.53 — upside +28%
🎯 on LGND : no call matured yet · 📊 on Health : 51.9% · +3.9% (156 calls)
in progress (365j)
matures : Jul 9, 27
matures : Jul 9, 27
▲ Buy · 🎯$332
Price at call : $322.61 — upside +3%
Today : $303.53 — upside +9%
🎯 on LGND : 100% (1 call matured) · 📊 on Health : 44.3% · +6.0% (97 calls)
in progress (365j)
matures : Jul 8, 27
matures : Jul 8, 27
RBC Capital ↗
May 8, 26
▲ Outperform · 🎯$262
Price at call : $220.48 — upside +19%
Today : $303.53 — upside -14%
🎯 on LGND : 100% (4 calls matureds) · 📊 on Health : 31.1% · -10.5% (167 calls)
in progress (365j)
matures : May 8, 27
matures : May 8, 27
HC Wainwright & Co. ↗
Apr 30, 26
▲ Buy · 🎯$289
Price at call : $229.45 — upside +26%
Today : $303.53 — upside -5%
🎯 on LGND : 100% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Apr 30, 27
matures : Apr 30, 27
RBC Capital ↗
Apr 28, 26
▲ Outperform · 🎯$252
Price at call : $224.86 — upside +12%
Today : $303.53 — upside -17%
🎯 on LGND : 100% (4 calls matureds) · 📊 on Health : 31.1% · -10.5% (167 calls)
in progress (365j)
matures : Apr 28, 27
matures : Apr 28, 27
▲ Buy · 🎯$282
Price at call : $223.24 — upside +26%
Today : $303.53 — upside -7%
🎯 on LGND : no call matured yet · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : Apr 15, 27
matures : Apr 15, 27
HC Wainwright & Co. ↗
Apr 14, 26
▲ Buy · 🎯$243
Price at call : $225.09 — upside +8%
Today : $303.53 — upside -20%
🎯 on LGND : 100% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Apr 14, 27
matures : Apr 14, 27
▲ Buy · 🎯$276
Price at call : $204.56 — upside +35%
Today : $303.53 — upside -9%
🎯 on LGND : no call matured yet · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : Mar 24, 27
matures : Mar 24, 27
B of A Securities ↗
Mar 11, 26
▲ Buy · 🎯$244
Price at call : $221.24 — upside +10%
Today : $303.53 — upside -20%
🎯 on LGND : no call matured yet · 📊 on Health : 51.9% · +3.9% (156 calls)
in progress (365j)
matures : Mar 11, 27
matures : Mar 11, 27
Oppenheimer ↗
Feb 27, 26
▲ Outperform · 🎯$277
Price at call : $202.55 — upside +37%
Today : $303.53 — upside -9%
🎯 on LGND : 100% (6 calls matureds) · 📊 on Health : 47.4% · +5.9% (95 calls)
in progress (365j)
matures : Feb 27, 27
matures : Feb 27, 27
HC Wainwright & Co. ↗
Feb 24, 26
▲ Buy · 🎯$239
Price at call : $191.39 — upside +25%
Today : $303.53 — upside -21%
🎯 on LGND : 100% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Feb 24, 27
matures : Feb 24, 27
RBC Capital ↗
Dec 10, 25
▲ Outperform · 🎯$235
Price at call : $184.03 — upside +28%
Today : $303.53 — upside -23%
🎯 on LGND : 100% (4 calls matureds) · 📊 on Health : 31.1% · -10.5% (167 calls)
in progress (365j)
matures : Dec 10, 26
matures : Dec 10, 26
▲ Buy · 🎯$230
Price at call : $184.03 — upside +25%
Today : $303.53 — upside -24%
🎯 on LGND : 100% (1 call matured) · 📊 on Health : 44.3% · +6.0% (97 calls)
in progress (365j)
matures : Dec 10, 26
matures : Dec 10, 26
▲ Buy · 🎯$270
Price at call : $184.03 — upside +47%
Today : $303.53 — upside -11%
🎯 on LGND : no call matured yet · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : Dec 9, 26
matures : Dec 9, 26
RBC Capital ↗
Nov 10, 25
▲ Outperform · 🎯$234
Price at call : $208.7 — upside +12%
Today : $303.53 — upside -23%
🎯 on LGND : 100% (4 calls matureds) · 📊 on Health : 31.1% · -10.5% (167 calls)
in progress (365j)
matures : Nov 10, 26
matures : Nov 10, 26
▲ Buy · 🎯$220
Price at call : $209.29 — upside +5%
Today : $303.53 — upside -28%
🎯 on LGND : 100% (11 calls matureds) · 📊 on Health : 47.8% · +2.9% (69 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
Oppenheimer ↗
Nov 7, 25
▲ Outperform · 🎯$275
Price at call : $202.48 — upside +36%
Today : $303.53 — upside -9%
🎯 on LGND : 100% (6 calls matureds) · 📊 on Health : 47.4% · +5.9% (95 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
HC Wainwright & Co. ↗
Nov 6, 25
▲ Buy · 🎯$231
Price at call : $202.48 — upside +14%
Today : $303.53 — upside -24%
🎯 on LGND : 100% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
Oppenheimer ↗
Nov 3, 25
▲ Outperform · 🎯$250
Price at call : $189.45 — upside +32%
Today : $303.53 — upside -18%
🎯 on LGND : 100% (6 calls matureds) · 📊 on Health : 47.4% · +5.9% (95 calls)
in progress (365j)
matures : Nov 3, 26
matures : Nov 3, 26
Oppenheimer ↗
Sep 3, 25
▲ Outperform · 🎯$190
Price at call : $167.74 — upside +13%
Today : $303.53 — upside -37%
Expected +13% · Actual +70% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (6 calls matureds) · 📊 on Health : 47.4% · +5.9% (95 calls)
+70.3%
stock +70% · XLV +25%
matured Sep 3, 26
▲ Buy · 🎯$175
Price at call : $166.54 — upside +5%
Today : $303.53 — upside -42%
Expected +5% · Actual +74% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (11 calls matureds) · 📊 on Health : 47.8% · +2.9% (69 calls)
+74.0%
stock +74% · XLV +27%
matured Sep 2, 26
HC Wainwright & Co. ↗
Aug 28, 25
▲ Buy · 🎯$206
Price at call : $161.71 — upside +27%
Today : $303.53 — upside -32%
Expected +27% · Actual +76% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+75.7%
stock +76% · XLV +24%
matured Aug 28, 26
RBC Capital ↗
Aug 8, 25
▲ Outperform · 🎯$185
Price at call : $147.01 — upside +26%
Today : $303.53 — upside -39%
Expected +26% · Actual +101% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (4 calls matureds) · 📊 on Health : 31.1% · -10.5% (167 calls)
+101.1%
stock +101% · XLV +29%
matured Aug 8, 26
Oppenheimer ↗
Aug 7, 25
▲ Outperform · 🎯$167
Price at call : $146.32 — upside +14%
Today : $303.53 — upside -45%
Expected +14% · Actual +100% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (6 calls matureds) · 📊 on Health : 47.4% · +5.9% (95 calls)
+100.4%
stock +100% · XLV +28%
matured Aug 7, 26
Oppenheimer ↗
Jul 30, 25
▲ Outperform · 🎯$162
Price at call : $131.58 — upside +23%
Today : $303.53 — upside -47%
Expected +23% · Actual +119% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (6 calls matureds) · 📊 on Health : 47.4% · +5.9% (95 calls)
+118.5%
stock +119% · XLV +25%
matured Jul 30, 26
Oppenheimer ↗
May 9, 25
▲ Outperform · 🎯$145
Price at call : $106.38 — upside +36%
Today : $303.53 — upside -52%
Expected +36% · Actual +107% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (6 calls matureds) · 📊 on Health : 47.4% · +5.9% (95 calls)
+107.3%
stock +107% · XLV +5%
matured May 9, 26
▲ Buy · 🎯$143
Price at call : $101.29 — upside +41%
Today : $303.53 — upside -53%
Expected +41% · Actual +102% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (1 call matured) · 📊 on Health : 44.3% · +6.0% (97 calls)
+102.3%
stock +102% · XLV +9%
matured Apr 10, 26
▲ Buy · 🎯$135
Price at call : $113.8 — upside +19%
Today : $303.53 — upside -56%
Expected +19% · Actual +73% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (11 calls matureds) · 📊 on Health : 47.8% · +2.9% (69 calls)
+73.5%
stock +73% · XLV +12%
matured Dec 23, 25
▲ Overweight · 🎯$160
Price at call : $120.43 — upside +33%
Today : $303.53 — upside -47%
Expected +33% · Actual +62% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (3 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
+61.6%
stock +62% · XLV +10%
matured Dec 16, 25
RBC Capital ↗
Dec 11, 24
▲ Outperform · 🎯$143
Price at call : $113.51 — upside +26%
Today : $303.53 — upside -53%
Expected +26% · Actual +67% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (4 calls matureds) · 📊 on Health : 31.1% · -10.5% (167 calls)
+67.0%
stock +67% · XLV +9%
matured Dec 11, 25
HC Wainwright & Co. ↗
Dec 11, 24
▲ Buy
Actual +52% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+52.1%
stock +52% · XLV +8%
matured Dec 11, 25
RBC Capital ↗
Nov 12, 24
▲ Outperform · 🎯$140
Price at call : $120.74 — upside +16%
Today : $303.53 — upside -54%
Expected +16% · Actual +70% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (4 calls matureds) · 📊 on Health : 31.1% · -10.5% (167 calls)
+70.3%
stock +70% · XLV +4%
matured Nov 12, 25
▲ Buy · 🎯$135
Price at call : $123.47 — upside +9%
Today : $303.53 — upside -56%
Expected +9% · Actual +70% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (11 calls matureds) · 📊 on Health : 47.8% · +2.9% (69 calls)
+69.5%
stock +70% · XLV -1%
matured Nov 8, 25
▲ Overweight · 🎯$150
Price at call : $123.47 — upside +21%
Today : $303.53 — upside -51%
Expected +21% · Actual +70% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (3 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
+69.5%
stock +70% · XLV -1%
matured Nov 8, 25
Oppenheimer ↗
Nov 8, 24
▲ Outperform · 🎯$147
Price at call : $123.47 — upside +19%
Today : $303.53 — upside -52%
Expected +19% · Actual +70% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (6 calls matureds) · 📊 on Health : 47.4% · +5.9% (95 calls)
+69.5%
stock +70% · XLV -1%
matured Nov 8, 25
HC Wainwright & Co. ↗
Nov 8, 24
▲ Buy · 🎯$157
Price at call : $121.25 — upside +29%
Today : $303.53 — upside -48%
Expected +29% · Actual +73% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+72.6%
stock +73% · XLV -2%
matured Nov 8, 25
HC Wainwright & Co. ↗
Oct 31, 24
▲ Buy · 🎯$157
Price at call : $110.04 — upside +43%
Today : $303.53 — upside -48%
Expected +43% · Actual +74% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+73.8%
stock +74% · XLV -2%
matured Oct 31, 25
▲ Overweight · 🎯$125
Price at call : $115.53 — upside +8%
Today : $303.53 — upside -59%
Expected +8% · Actual +60% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (3 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
+59.7%
stock +60% · XLV -3%
matured Oct 28, 25
HC Wainwright & Co. ↗
Oct 21, 24
▲ Buy · 🎯$157
Price at call : $106.78 — upside +47%
Today : $303.53 — upside -48%
Expected +47% · Actual +75% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+74.8%
stock +75% · XLV -4%
matured Oct 21, 25
Oppenheimer ↗
Oct 3, 24
▲ Outperform · 🎯$135
Price at call : $102.24 — upside +32%
Today : $303.53 — upside -56%
Expected +32% · Actual +77% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (6 calls matureds) · 📊 on Health : 47.4% · +5.9% (95 calls)
+77.0%
stock +77% · XLV -4%
matured Oct 3, 25
▲ Buy · 🎯$110
Price at call : $103.02 — upside +7%
Today : $303.53 — upside -64%
Expected +7% · Actual +51% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (11 calls matureds) · 📊 on Health : 47.8% · +2.9% (69 calls)
+51.4%
stock +51% · XLV -12%
matured Aug 12, 25
RBC Capital ↗
Aug 12, 24
▲ Outperform · 🎯$130
Price at call : $103.02 — upside +26%
Today : $303.53 — upside -57%
Expected +26% · Actual +51% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (4 calls matureds) · 📊 on Health : 31.1% · -10.5% (167 calls)
+51.4%
stock +51% · XLV -12%
matured Aug 12, 25
HC Wainwright & Co. ↗
Aug 8, 24
▲ Buy · 🎯$144
Price at call : $96.92 — upside +49%
Today : $303.53 — upside -53%
Expected +49% · Actual +55% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+54.8%
stock +55% · XLV -13%
matured Aug 8, 25
HC Wainwright & Co. ↗
Jul 8, 24
▲ Buy · 🎯$144
Price at call : $91.71 — upside +57%
Today : $303.53 — upside -53%
Expected +57% · Actual +33% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+33.5%
stock +33% · XLV -7%
matured Jul 8, 25
▲ Buy · 🎯$95
Price at call : $84.85 — upside +12%
Today : $303.53 — upside -69%
Expected +12% · Actual +34% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (11 calls matureds) · 📊 on Health : 47.8% · +2.9% (69 calls)
+34.0%
stock +34% · XLV -7%
matured Jun 28, 25
HC Wainwright & Co. ↗
Jun 27, 24
▲ Buy · 🎯$144
Price at call : $84.26 — upside +71%
Today : $303.53 — upside -53%
Expected +71% · Actual +35% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+34.9%
stock +35% · XLV -8%
matured Jun 27, 25
HC Wainwright & Co. ↗
May 8, 24
▲ Buy · 🎯$144
Price at call : $80.36 — upside +79%
Today : $303.53 — upside -53%
Expected +79% · Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+27.6%
stock +28% · XLV -6%
matured May 8, 25
▲ Buy · 🎯$95
Price at call : $81.36 — upside +17%
Today : $303.53 — upside -69%
Expected +17% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (11 calls matureds) · 📊 on Health : 47.8% · +2.9% (69 calls)
+31.0%
stock +31% · XLV -0%
matured Apr 12, 25
HC Wainwright & Co. ↗
Feb 29, 24
▲ Buy · 🎯$144
Price at call : $78.7 — upside +83%
Today : $303.53 — upside -53%
Expected +83% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+42.5%
stock +43% · XLV +2%
matured Feb 28, 25
▲ Buy · 🎯$95
Price at call : $67.71 — upside +40%
Today : $303.53 — upside -69%
Expected +40% · Actual +73% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (11 calls matureds) · 📊 on Health : 47.8% · +2.9% (69 calls)
+72.7%
stock +73% · XLV +4%
matured Dec 12, 24
HC Wainwright & Co. ↗
Sep 19, 23
▲ Buy · 🎯$144
Price at call : $61.06 — upside +136%
Today : $303.53 — upside -53%
Expected +136% · Actual +72% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+72.0%
stock +72% · XLV +19%
matured Sep 18, 24
▲ Buy · 🎯$95
Price at call : $66.08 — upside +44%
Today : $303.53 — upside -69%
Expected +44% · Actual +57% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (11 calls matureds) · 📊 on Health : 47.8% · +2.9% (69 calls)
+57.1%
stock +57% · XLV +17%
matured Aug 22, 24
HC Wainwright & Co. ↗
Aug 9, 23
▲ Buy · 🎯$144
Price at call : $70.72 — upside +104%
Today : $303.53 — upside -53%
Expected +104% · Actual +37% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+37.0%
stock +37% · XLV +11%
matured Aug 8, 24
▲ Buy · 🎯$95
Price at call : $70.88 — upside +34%
Today : $303.53 — upside -69%
Expected +34% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on LGND : 100% (11 calls matureds) · 📊 on Health : 47.8% · +2.9% (69 calls)
+2.5%
stock +3% · XLV +12%
matured Feb 21, 24
▲ Buy · 🎯$81.0979
Price at call : $61.39 — upside +32%
Today : $303.53 — upside -73%
Expected +32% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (11 calls matureds) · 📊 on Health : 47.8% · +2.9% (69 calls)
+17.5%
stock +17% · XLV +2%
matured Feb 22, 23
▲ Buy
Actual +120% · Reason (≥ +15%) : ✓ Yes
🎯 on LGND : 100% (11 calls matureds) · 📊 on Health : 47.8% · +2.9% (69 calls)
+119.5%
stock +120% · XLV +11%
matured Feb 5, 21
CJS Securities
Jun 22, 15
■ Market Perform neutral · not a buy
🎯 on LGND : no call matured yet · 📊 on Health : 50% · +29.5% (6 calls)
in progress (365j)
matures : Jun 21, 16
matures : Jun 21, 16
Frequently asked questions
Should I buy Ligand Pharmaceuticals, Inc. stock?
This isn't buy advice. For Ligand Pharmaceuticals, Inc., the analyst consensus is "Buy", with an average price target of $345 (+14% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (6 calls tracked on Ligand Pharmaceuticals, Inc.). We show the numbers — you decide.
Is it too late to buy Ligand Pharmaceuticals, Inc.? How high can it go?
The most bullish analyst target on Ligand Pharmaceuticals, Inc. is $397 (+31% above today's price); the average is $345. That's the upside they see. Check how reliable those analysts have actually been on Ligand Pharmaceuticals, Inc. on our site before trusting it.
Is Ligand Pharmaceuticals, Inc. still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 10 analysts have a real record on Ligand Pharmaceuticals, Inc., the best hitting 100% over 6 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Ligand Pharmaceuticals, Inc.? The case for and against
The arguments for and against, one by one, from the numbers: why invest in LGND (and why hesitate).
What has Ligand Pharmaceuticals, Inc.'s past performance been?
Historical returns and a "how much if I had invested" calculator: LGND performance & returns.
What is the best month to buy LGND?
The 12 months ranked by the stock's past returns: best & worst month to buy LGND.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX